메뉴 건너뛰기
Psychiatric Annals
Volumn 31, Issue 12, 2001, Pages 715-722
Cytochrome enzyme genotype and the prediction of therapeutic response to psychotropics
Author keywords

[No Author keywords available]
Indexed keywords

EID: 23044531657     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20011201-07     Document Type: Article
Times cited : (5)
References (8)
  • 2
    • 0035895505 scopus 로고    scopus 로고
    • The sequence of the human genome
    • Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science. 2001;291:1304-1351.
    • (2001) Science , vol.291 , pp. 1304-1351
    • Venter, J.C.1    Adams, M.D.2    Myers, E.W.3
  • 3
    • 0035071598 scopus 로고    scopus 로고
    • Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
    • Kuelh P, Zhang J, Lin Y, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet. 2001;27:383-391.
    • (2001) Nat Genet , vol.27 , pp. 383-391
    • Kuelh, P.1    Zhang, J.2    Lin, Y.3
  • 5
    • 0034114843 scopus 로고    scopus 로고
    • The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population
    • Fukuda T, Nishida Y, Zhou Q, Yamamoto I, Kondo S, Azuma J. The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population. Eur J Clin Phannacol. 2000;56:175-180.
    • (2000) Eur J Clin Phannacol , vol.56 , pp. 175-180
    • Fukuda, T.1    Nishida, Y.2    Zhou, Q.3    Yamamoto, I.4    Kondo, S.5    Azuma, J.6
  • 6
    • 0001697297 scopus 로고    scopus 로고
    • Extension of a pilot study: Impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness
    • Chou WH, Yan FX, de Leon J, et al. Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness. J Clin Psychopharmacol. 2000;20:246-251.
    • (2000) J Clin Psychopharmacol , vol.20 , pp. 246-251
    • Chou, W.H.1    Yan, F.X.2    De Leon, J.3
  • 7
    • 0030910635 scopus 로고    scopus 로고
    • Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients
    • Andreassen OA, MacEwan T, Gulbrandsen AK, et al. Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients. Psychopharmacology (Berl). 1997;131:174-179.
    • (1997) Psychopharmacology (Berl) , vol.131 , pp. 174-179
    • Andreassen, O.A.1    MacEwan, T.2    Gulbrandsen, A.K.3
  • 8
    • 0030809767 scopus 로고    scopus 로고
    • Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotype
    • Armstrong M, Daly AK, Blennerhasset R, Ferrier N, Idle JR. Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotype. Br J Psychiatry. 1997;170:23-26.
    • (1997) Br J Psychiatry , vol.170 , pp. 23-26
    • Armstrong, M.1    Daly, A.K.2    Blennerhasset, R.3    Ferrier, N.4    Idle, J.R.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.